A Multicentre Study of Wastewater and Antibiotic Resistance in Care Homes.
E-FLUENT
Multicentre Study Analysing Wastewater to Monitor Bacterial Resistance to Antibiotics in Residential Care Homes for Elderly Dependent.
1 other identifier
observational
1,600
1 country
2
Brief Summary
This study aims to model the relationship between the prevalence of ESBL-E and CPE carriage among nursing home residents and their respective concentrations in wastewater discharged from the facility.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2026
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 14, 2025
CompletedFirst Posted
Study publicly available on registry
November 18, 2025
CompletedStudy Start
First participant enrolled
March 16, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2027
April 16, 2026
November 1, 2025
1 year
November 14, 2025
April 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Predictive performance
The primary endpoint will be the adequacy and predictive performance of the model for estimating the prevalence of ESBL-E/CPE carriage among nursing home residents. Carriage prevalence will be measured by collecting stool samples from residents or, failing that, by anorectal swabs.
15 months
Secondary Outcomes (1)
Epidemiology of ESBL/CPE in nursing homes
15 months
Eligibility Criteria
Nursing home residents located in Loire-Atlantique and Maine-et-Loire, France
You may qualify if:
- Residents present on the day of sampling (D0 or D+1) in a facility selected during randomization, without criteria regarding length of stay in the facility, and whose health status on the day of the survey permits it;
- Residents who, based on clinical criteria (including an MMSE greater than or equal to 20), are deemed by the nursing home team to be able to understand the issues of the study and to express an informed non-opposition; OR Residents who the nursing home team considers unable to express an informed non-objection but who have a legal representative, a trusted person, or a loved one capable of understanding the information and expressing an informed non-objection.
- Residents may be included regardless of the presence of infection, diarrheal stools, antibiotic use or any other treatment, or health status.
- Participants in this study may participate in other research projects concurrently.
You may not qualify if:
- Residents whose health status is incompatible with performing the procedure on the day of the survey (e.g., end-of-life with comfort care);
- Residents with a Mini Mental State Examination (MMSE) score of less than or equal to 20, or without an MMSE score but who, according to nursing home professionals, are unable to provide an informed non-objection and who do not have a legal representative, trusted person, or relative capable of receiving information and providing an informed non-objection;
- Residents, regardless of their MMSE score, who refuse to have the sample taken on the day of the survey even if their legal repre
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
CHU d'Angers
Angers, 49100, France
CHU de Nantes
Nantes, 44093, France
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 14, 2025
First Posted
November 18, 2025
Study Start
March 16, 2026
Primary Completion (Estimated)
March 31, 2027
Study Completion (Estimated)
June 30, 2027
Last Updated
April 16, 2026
Record last verified: 2025-11